Suzhou Basecare Medical Corporation Limited (HKG:2170)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.920
+0.020 (1.05%)
Apr 29, 2026, 2:25 PM HKT
-41.64%
Market Cap 519.70M
Revenue (ttm) 259.59M
Net Income (ttm) -248.66M
Shares Out 273.53M
EPS (ttm) -0.91
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,500
Average Volume 70,450
Open 1.900
Previous Close 1.900
Day's Range 1.900 - 1.920
52-Week Range 1.780 - 4.360
Beta 0.16
RSI 45.44
Earnings Date Mar 30, 2026

About HKG:2170

Suzhou Basecare Medical Corporation Limited, an investment holding company provides genetic testing solutions for assisted human reproduction in the People’s Republic of China and Australia. The company offers pre-implantation genetic test kits, including PGT-A kit to detect aneuploidy; PGT-M kit to detect single-gene or monogenic defects in pre-implantation embryos; and PGT-SR kit to detect chromosome structural rearrangements, which are common causes of recurrent miscarriage. It also provides DA500, a high-throughput gene sequencer that provi... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2010
Employees 407
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2170
Full Company Profile

Financial Performance

In 2025, HKG:2170's revenue was 233.27 million, a decrease of -22.01% compared to the previous year's 299.11 million. Losses were -223.46 million, -5.73% less than in 2024.

Financial numbers in CNY Financial Statements

News

There is no news available yet.